Russian Journal of Telemedicine and E-Health,
Journal Year:
2023,
Volume and Issue:
9(4), P. 14 - 22
Published: Dec. 25, 2023
Digital
technology
is
the
fastest
growing
area
with
major
implications
for
healthcare.
In
neurology,
this
can
provide
better
accessibility
in
consultations,
expanding
potential
of
various
diagnostic
and
therapeutic
tools
systems.
For
example,
telemedicine
allows
access
to
services,
overcoming
geographical
barriers,
thereby
providing
opportunity
medical
care
not
only
patients,
but
also
their
relatives.
The
widespread
introduction
artificial
intelligence
elements
into
routine
practice
a
neurologist
helps
make
decisions
on
diagnosis,
treatment,
assessment
development
prognosis
neurological
diseases.
This
article
describes
digital
health
technologies
neurodegenerative
diseases,
demyelinating
dementia,
stroke
epilepsy.
Journal of Clinical Medicine,
Journal Year:
2025,
Volume and Issue:
14(2), P. 550 - 550
Published: Jan. 16, 2025
The
convergence
of
Artificial
Intelligence
(AI)
and
neuroscience
is
redefining
our
understanding
the
brain,
unlocking
new
possibilities
in
research,
diagnosis,
therapy.
This
review
explores
how
AI’s
cutting-edge
algorithms—ranging
from
deep
learning
to
neuromorphic
computing—are
revolutionizing
by
enabling
analysis
complex
neural
datasets,
neuroimaging
electrophysiology
genomic
profiling.
These
advancements
are
transforming
early
detection
neurological
disorders,
enhancing
brain–computer
interfaces,
driving
personalized
medicine,
paving
way
for
more
precise
adaptive
treatments.
Beyond
applications,
itself
has
inspired
AI
innovations,
with
architectures
brain-like
processes
shaping
advances
algorithms
explainable
models.
bidirectional
exchange
fueled
breakthroughs
such
as
dynamic
connectivity
mapping,
real-time
decoding,
closed-loop
systems
that
adaptively
respond
states.
However,
challenges
persist,
including
issues
data
integration,
ethical
considerations,
“black-box”
nature
many
systems,
underscoring
need
transparent,
equitable,
interdisciplinary
approaches.
By
synthesizing
latest
identifying
future
opportunities,
this
charts
a
path
forward
integration
neuroscience.
From
harnessing
multimodal
cognitive
augmentation,
fusion
these
fields
not
just
brain
science,
it
reimagining
human
potential.
partnership
promises
where
mysteries
unlocked,
offering
unprecedented
healthcare,
technology,
beyond.
Acta Epileptologica,
Journal Year:
2025,
Volume and Issue:
7(1)
Published: Jan. 3, 2025
Abstract
Epilepsy,
characterized
by
recurrent
seizures,
is
influenced
biological
rhythms,
such
as
circadian,
seasonal,
and
menstrual
cycles.
These
rhythms
affect
the
frequency,
severity,
timing
of
although
precise
mechanisms
underlying
these
associations
remain
unclear.
This
review
examines
role
clocks,
particularly
core
circadian
genes
Bmal1
,
Clock
Per
Cry
in
regulating
neuronal
excitability
epilepsy
susceptibility.
We
explore
how
sleep-wake
cycle,
non-rapid
eye
movement
sleep,
increases
risk
discuss
modulation
neurotransmitters
like
gamma-aminobutyric
acid
glutamate.
clinical
implications,
including
chronotherapy
which
refers
to
practice
medical
treatments
align
with
body's
natural
rhythm.
Chronotherapy
aligns
anti-seizure
medication
administration
rhythms.
also
rhythm-based
neuromodulation
strategies,
adaptive
deep
brain
stimulation,
may
dynamically
change
stimulation
response
predicted
seizures
patients,
provide
additional
therapeutic
options.
emphasizes
potential
integrating
rhythm
analysis
into
personalized
management,
offering
novel
approaches
optimize
treatment
improve
patient
outcomes.
Future
research
should
focus
on
understanding
individual
variability
seizure
harnessing
technological
innovations
enhance
prediction,
precision
treatment,
long-term
management.
Health Science Reports,
Journal Year:
2025,
Volume and Issue:
8(1)
Published: Jan. 1, 2025
ABSTRACT
Background
and
Aim
Epilepsy
is
a
major
neurological
challenge,
especially
for
pediatric
populations.
It
profoundly
impacts
both
developmental
progress
quality
of
life
in
affected
children.
With
the
advent
artificial
intelligence
(AI),
there's
growing
interest
leveraging
its
capabilities
to
improve
diagnosis
management
epilepsy.
This
review
aims
assess
effectiveness
AI
epilepsy
detection
while
considering
ethical
implications
surrounding
implementation.
Methodology
A
comprehensive
systematic
was
conducted
across
multiple
databases
including
PubMed,
EMBASE,
Google
Scholar,
Scopus,
Medline.
Search
terms
encompassed
“pediatric
epilepsy,”
“artificial
intelligence,”
“machine
learning,”
“ethical
considerations,”
“data
security.”
Publications
from
past
decade
were
scrutinized
methodological
rigor,
with
focus
on
studies
evaluating
AI's
efficacy
management.
Results
systems
have
demonstrated
strong
potential
diagnosing
monitoring
epilepsy,
often
matching
clinical
accuracy.
For
example,
AI‐driven
decision
support
achieved
93.4%
accuracy
diagnosis,
closely
aligning
expert
assessments.
Specific
methods,
like
EEG‐based
detecting
interictal
discharges,
showed
high
specificity
(93.33%–96.67%)
sensitivity
(76.67%–93.33%),
neuroimaging
approaches
using
rs‐fMRI
DTI
reached
up
97.5%
identifying
microstructural
abnormalities.
Deep
learning
models,
such
as
CNN‐LSTM,
also
enhanced
seizure
video
by
capturing
subtle
movement
expression
cues.
Non‐EEG
sensor‐based
methods
effectively
identified
nocturnal
seizures,
offering
promising
care.
However,
considerations
around
privacy,
data
security,
model
bias
remain
crucial
responsible
integration.
Conclusion
While
holds
immense
enhance
management,
transparency,
fairness,
security
must
be
rigorously
addressed.
Collaborative
efforts
among
stakeholders
are
imperative
navigate
these
challenges
effectively,
ensuring
integration
optimizing
patient
outcomes
Biosensors,
Journal Year:
2024,
Volume and Issue:
14(4), P. 183 - 183
Published: April 9, 2024
The
rapid
development
of
biosensing
technologies
together
with
the
advent
deep
learning
has
marked
an
era
in
healthcare
and
biomedical
research
where
widespread
devices
like
smartphones,
smartwatches,
health-specific
have
potential
to
facilitate
remote
accessible
diagnosis,
monitoring,
adaptive
therapy
a
naturalistic
environment.
This
systematic
review
focuses
on
impact
combining
multiple
techniques
algorithms
application
these
models
healthcare.
We
explore
key
areas
that
researchers
engineers
must
consider
when
developing
model
for
biosensing:
data
modality,
architecture,
real-world
use
case
model.
also
discuss
ongoing
challenges
future
directions
this
field.
aim
provide
useful
insights
who
seek
intelligent
advance
precision
Frontiers in Computational Neuroscience,
Journal Year:
2024,
Volume and Issue:
18
Published: June 17, 2024
Electroencephalogram
(EEG)
plays
a
pivotal
role
in
the
detection
and
analysis
of
epileptic
seizures,
which
affects
over
70
million
people
world.
Nonetheless,
visual
interpretation
EEG
signals
for
epilepsy
is
laborious
time-consuming.
To
tackle
this
open
challenge,
we
introduce
straightforward
yet
efficient
hybrid
deep
learning
approach,
named
ResBiLSTM,
detecting
seizures
using
signals.
Firstly,
one-dimensional
residual
neural
network
(ResNet)
tailored
to
adeptly
extract
local
spatial
features
Subsequently,
acquired
are
input
into
bidirectional
long
short-term
memory
(BiLSTM)
layer
model
temporal
dependencies.
These
output
further
processed
through
two
fully
connected
layers
achieve
final
seizure
detection.
The
performance
ResBiLSTM
assessed
on
datasets
provided
by
University
Bonn
Temple
Hospital
(TUH).
achieves
accuracy
rates
98.88–100%
binary
ternary
classifications
dataset.
Experimental
outcomes
recognition
across
seven
types
TUH
corpus
(TUSZ)
dataset
indicate
that
attains
classification
95.03%
weighted
F1
score
with
10-fold
cross-validation.
findings
illustrate
outperforms
several
recent
state-of-the-art
approaches.
Epilepsia,
Journal Year:
2024,
Volume and Issue:
unknown
Published: June 5, 2024
Abstract
Wearable
devices
have
attracted
significant
attention
in
epilepsy
research
recent
years
for
their
potential
to
enhance
patient
care
through
improved
seizure
monitoring
and
forecasting.
This
narrative
review
presents
a
detailed
overview
of
the
current
clinical
state
art
while
addressing
how
that
assess
autonomic
nervous
system
(ANS)
function
reflect
seizures
central
(CNS)
changes.
includes
description
interactions
between
CNS
ANS,
including
physiological
epilepsy‐related
changes
affecting
dynamics.
We
first
discuss
technical
aspects
measuring
biosignals
considerations
using
ANS
sensors
practice.
then
detection
forecasting
studies,
highlighting
performance
capability
biomarkers.
Finally,
we
address
field's
challenges
provide
an
outlook
future
developments.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 29, 2025
A
bstract
The
unpredictability
of
seizures
is
one
the
most
compromising
features
reported
by
people
with
epilepsy.
Non-stigmatizing
and
easy-to-use
wearable
devices
may
provide
information
to
predict
based
on
physiological
data.
We
propose
a
patient-agnostic
seizure
prediction
method
that
identifies
group-level
patterns
across
data
from
multiple
patients.
employ
supervised
long-short-term
networks
(LSTMs)
add
unsupervised
deep
canonically
correlated
autoencoders
(DCCAE)
24-hour
using
time-of-day
information.
fuse
these
three
techniques
growing
neural
network,
allowing
incremental
learning.
Our
all
improves
accuracy
over
baseline
LSTM
7.3%,
74.4%
81.7%,
averaged
patients,
outperforms
in
84%
Compared
all-at-once
fusion,
network
9.5%.
analyze
impact
preictal
duration,
quality,
clinical
variables
performance.
Developmental Medicine & Child Neurology,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 31, 2025
Wearable
sensors
have
the
potential
to
transform
diagnosis,
monitoring,
and
management
of
children
who
neurological
conditions.
Traditional
methods
for
assessing
disorders
rely
on
clinical
scales
subjective
measures.
The
snapshot
disease
progression
at
a
particular
time
point,
lack
cooperation
by
during
assessments,
susceptibility
bias
limit
utility
these
sensors,
which
capture
data
continuously
in
natural
settings,
offer
non-invasive
objective
alternative
traditional
methods.
This
review
examines
role
wearable
various
paediatric
conditions,
including
cerebral
palsy,
epilepsy,
autism
spectrum
disorder,
attention-deficit/hyperactivity
as
well
Rett
syndrome,
Down
Angelman
Prader-Willi
neuromuscular
such
Duchenne
muscular
dystrophy
spinal
atrophy,
ataxia,
Gaucher
disease,
headaches,
sleep
disorders.
highlights
their
application
tracking
motor
function,
seizure
activity,
daily
movement
patterns
gain
insights
into
therapeutic
response.
Although
challenges
related
population
size,
compliance,
ethics,
regulatory
approval
remain,
technology
promises
improve
trials
outcomes
patients
neurology.
Acta Epileptologica,
Journal Year:
2025,
Volume and Issue:
7(1)
Published: Feb. 19, 2025
Abstract
Epilepsy
is
one
of
the
most
common
neurological
disorders,
affecting
more
than
50
million
people
worldwide.
Management
particularly
complex
in
individuals
with
intellectual
disabilities,
who
are
at
a
much
higher
risk
having
severe
seizures
compared
to
general
population.
People
disabilities
regularly
excluded
from
epilepsy
research,
despite
significantly
risks
negative
health
outcomes
and
early
mortality.
Recent
advances
artificial
intelligence
(AI)
have
shown
great
potential
improving
diagnosis,
monitoring,
management
epilepsy.
Machine
learning
techniques
been
used
analysing
electroencephalography
data
for
efficient
seizure
detection
prediction,
as
well
individualised
treatment,
which
facilitates
timely
customised
intervention
Research
implementation
AI-based
solutions
still
remains
limited
due
lack
accessible
long-term
clinical
model
training,
difficulties
communicating
ethical
challenges
ensuring
safety
AI
systems
this
This
paper
presents
an
overview
recent
applications
highlighting
key
necessity
including
research
on
epilepsy,
strategies
promote
development
use
vulnerable
Given
prevalence
consequences
associated
application
care
has
significant
positive
impact.
To
achieve
impact
avoid
increasing
existing
inequity,
there
urgent
need
greater
inclusion
around
management.